{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:24:31Z","timestamp":1790807071081,"version":"4.1.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"6","funder":[{"DOI":"10.13039\/100011541","name":"National Cancer Institute Division of Cancer Epidemiology and Genetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center for Cancer Research"},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Conquer Cancer Foundation of the American Society of Clinical Oncology Young Investigator Award"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Li-Fraumeni syndrome (LFS) is a highly penetrant autosomal dominant cancer predisposition disorder caused by germline TP53 pathogenic variants. Patients with LFS have increased oxidative phosphorylation capacity in skeletal muscle and oxidative stress in blood. Metformin inhibits oxidative phosphorylation, reducing available energy for cancer cell proliferation and decreasing production of reactive oxygen species that cause DNA damage. Thus, metformin may provide pharmacologic risk reduction for cancer in patients with LFS, but its safety in nondiabetic patients with germline TP53 pathogenic variants has not been documented.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This study assessed safety and tolerability of metformin in nondiabetic LFS patients and measured changes in metabolic profiles. Adult patients with LFS and germline TP53 variant received 14\u2009weeks of metformin. Blood samples were obtained for measurement of serum insulin-like growth factor\u20131, insulin, and insulin-like growth factor binding protein 3. Hepatic mitochondrial function was assessed with fasting exhaled CO2 after ingestion of 13C-labeled methionine. Changes in serum metabolome were measured. All statistical tests were 2-sided.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We enrolled 26 participants: 20 females and 6 males. The most common adverse events were diarrhea (50.0%) and nausea (46.2%). Lactic acidosis did not occur, and there were no changes in fasting glucose. Cumulative mean 13C exhalation was statistically significantly suppressed by metformin (P = .001). Mean levels of insulin-like growth factor binding protein 3 and insulin-like growth factor-1 were statistically significantly lowered (P = .02). Lipid metabolites and branched-chain amino acids accumulated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Metformin was safe and tolerable in patients with LFS. It suppressed hepatic mitochondrial function as expected in these individuals. This study adds to the rationale for development of a pharmacologic risk-reduction clinical trial of metformin in LFS.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jncics\/pkaa063","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T19:08:26Z","timestamp":1594753706000},"source":"Crossref","is-referenced-by-count":16,"title":["Pilot Study Assessing Tolerability and Metabolic Effects of Metformin in Patients With Li-Fraumeni Syndrome"],"prefix":"10.1093","volume":"4","author":[{"given":"Farzana L","family":"Walcott","sequence":"first","affiliation":[{"name":"Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA"},{"name":"Oncology R&D,AstraZeneca, Gaithersburg, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Yuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Cardiovascular Branch, National Heart Lung Blood Institute, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M","family":"Bryla","sequence":"additional","affiliation":[{"name":"Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca D","family":"Huffstutler","sequence":"additional","affiliation":[{"name":"Cardiovascular Branch, National Heart Lung Blood Institute, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Singh","sequence":"additional","affiliation":[{"name":"George Washington Medical School, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael N","family":"Pollak","sequence":"additional","affiliation":[{"name":"McGill University, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payal P","family":"Khincha","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6006-0740","authenticated-orcid":false,"given":"Sharon A","family":"Savage","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7486-4974","authenticated-orcid":false,"given":"Phuong L","family":"Mai","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA"},{"name":"Current affiliation: Magee-Womens Hospital, University of Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin W","family":"Dodd","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5976-7834","authenticated-orcid":false,"given":"Paul M","family":"Hwang","sequence":"additional","affiliation":[{"name":"Cardiovascular Branch, National Heart Lung Blood Institute, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio T","family":"Fojo","sequence":"additional","affiliation":[{"name":"Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA"},{"name":"Current affiliation: Columbia University, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M","family":"Annunziata","sequence":"additional","affiliation":[{"name":"Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,18]]},"reference":[{"issue":"4","key":"2021012107025211400_pkaa063-B1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/1947601911413466","article-title":"Li-Fraumeni syndrome","volume":"2","author":"Malkin","year":"2011","journal-title":"Genes Cancer"},{"issue":"23","key":"2021012107025211400_pkaa063-B2","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1002\/cncr.30248","article-title":"Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort","volume":"122","author":"Mai","year":"2016","journal-title":"Cancer"},{"issue":"12","key":"2021012107025211400_pkaa063-B3","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1001\/jamaoncol.2017.1968","article-title":"Baseline surveillance in Li-Fraumeni syndrome using whole-body magnetic resonance imaging: a meta-analysis","volume":"3","author":"Ballinger","year":"2017","journal-title":"JAMA Oncol"},{"issue":"9","key":"2021012107025211400_pkaa063-B4","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S1470-2045(16)30249-2","article-title":"Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study","volume":"17","author":"Villani","year":"2016","journal-title":"Lancet Oncol"},{"issue":"6","key":"2021012107025211400_pkaa063-B5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1470-2045(11)70119-X","article-title":"Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study","volume":"12","author":"Villani","year":"2011","journal-title":"Lancet Oncol"},{"key":"2021012107025211400_pkaa063-B6","author":"National Comprehensive Cancer Network"},{"issue":"1","key":"2021012107025211400_pkaa063-B7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/j.gastro.2018.09.036","article-title":"Earlier colorectal cancer screening may be necessary in patients with Li-Fraumeni syndrome","volume":"156","author":"Macfarland","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"2021012107025211400_pkaa063-B8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1053\/j.gastro.2018.10.063","article-title":"Early-onset colorectal cancer in patients with Li Fraumeni syndrome: is it really enough to justify early colon cancer screening?","volume":"157","author":"Nirvana Da Cruz Formiga","year":"2019","journal-title":"Gastroenterology"},{"issue":"5930","key":"2021012107025211400_pkaa063-B9","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"issue":"3","key":"2021012107025211400_pkaa063-B10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"issue":"5","key":"2021012107025211400_pkaa063-B11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg's contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"2021012107025211400_pkaa063-B12","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrc2715","article-title":"p53 and metabolism","volume":"9","author":"Vousden","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"2021012107025211400_pkaa063-B13","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1089\/ars.2010.3650","article-title":"p53, aerobic metabolism, and cancer","volume":"15","author":"Lago","year":"2011","journal-title":"Antioxid Redox Signal"},{"issue":"10","key":"2021012107025211400_pkaa063-B14","doi-asserted-by":"crossref","first-page":"e47010","DOI":"10.1371\/journal.pone.0047010","article-title":"Increased oxidative damage in carriers of the germline TP53 p. R337H mutation","volume":"7","author":"Macedo","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"2021012107025211400_pkaa063-B15","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa1214091","article-title":"Increased oxidative metabolism in the Li-Fraumeni syndrome","volume":"368","author":"Wang","year":"2013","journal-title":"N Engl J Med"},{"key":"2021012107025211400_pkaa063-B16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.gde.2016.02.007","article-title":"TP53 mutation, mitochondria and cancer","volume":"38","author":"Kamp","year":"2016","journal-title":"Curr Opin Genet Dev"},{"issue":"1","key":"2021012107025211400_pkaa063-B17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1172\/JCI88668","article-title":"Inhibiting mitochondrial respiration prevents cancer in a mouse model of Li-Fraumeni syndrome","volume":"127","author":"Wang","year":"2016","journal-title":"J Clin Invest"},{"key":"2021012107025211400_pkaa063-B18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.arr.2017.08.003","article-title":"Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: a systematic review and meta-analysis","volume":"40","author":"Campbell","year":"2017","journal-title":"Ageing Res Rev"},{"issue":"9","key":"2021012107025211400_pkaa063-B19","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00125-017-4372-6","article-title":"Repurposing metformin for the prevention of cancer and cancer recurrence","volume":"60","author":"Heckman-Stoddard","year":"2017","journal-title":"Diabetologia"},{"issue":"7","key":"2021012107025211400_pkaa063-B20","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.2337\/dc14-0500","article-title":"Metformin and cancer: mounting evidence against an association","volume":"37","author":"Suissa","year":"2014","journal-title":"Diabetes Care"},{"issue":"9","key":"2021012107025211400_pkaa063-B21","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1172\/JCI67232","article-title":"Potential applications for biguanides in oncology","volume":"123","author":"Pollak","year":"2013","journal-title":"J Clin Invest"},{"issue":"1","key":"2021012107025211400_pkaa063-B22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.celrep.2018.06.008","article-title":"Uncoupling hepatic oxidative phosphorylation reduces tumor growth in two murine models of colon cancer","volume":"24","author":"Wang","year":"2018","journal-title":"Cell Rep"},{"issue":"3","key":"2021012107025211400_pkaa063-B23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrc3215","article-title":"The insulin and insulin-like growth factor receptor family in neoplasia: an update","volume":"12","author":"Pollak","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"18","key":"2021012107025211400_pkaa063-B24","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/jnci\/92.18.1472","article-title":"Role of the insulin-like growth factor family in cancer development and progression","volume":"92","author":"Yu","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"2021012107025211400_pkaa063-B25","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/1940-6207.CAPR-11-0536","article-title":"Metformin reduces endogenous reactive oxygen species and associated DNA damage","volume":"5","author":"Algire","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"2021012107025211400_pkaa063-B26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbcan.2018.06.001","article-title":"Control of metabolism by p53 - cancer and beyond","volume":"1870","author":"Labuschagne","year":"2018","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"2021012107025211400_pkaa063-B27","doi-asserted-by":"crossref","first-page":"E182","DOI":"10.1152\/ajpendo.00272.2005","article-title":"Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle","volume":"291","author":"Collier","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"2021012107025211400_pkaa063-B28","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nm.3596","article-title":"Overcoming drug development bottlenecks with repurposing: repurposing biguanides to target energy metabolism for cancer treatment","volume":"20","author":"Pollak","year":"2014","journal-title":"Nat Med"},{"issue":"7","key":"2021012107025211400_pkaa063-B29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tcb.2010.03.004","article-title":"The regulation of energy metabolism and the IGF-1\/mTOR pathways by the p53 protein","volume":"20","author":"Feng","year":"2010","journal-title":"Trends Cell Biol"},{"issue":"2","key":"2021012107025211400_pkaa063-B30","doi-asserted-by":"crossref","first-page":"a001057","DOI":"10.1101\/cshperspect.a001057","article-title":"p53 regulation of the IGF-1\/AKT\/mTOR pathways and the endosomal compartment","volume":"2","author":"Feng","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"2021012107025211400_pkaa063-B31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1101\/gad.1363206","article-title":"Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways","volume":"20","author":"Levine","year":"2006","journal-title":"Genes Dev"},{"issue":"5780","key":"2021012107025211400_pkaa063-B32","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1126863","article-title":"p53 regulates mitochondrial respiration","volume":"312","author":"Matoba","year":"2006","journal-title":"Science"},{"issue":"14","key":"2021012107025211400_pkaa063-B33","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.1158\/0008-5472.CAN-06-4447","article-title":"Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth","volume":"67","author":"Buzzai","year":"2007","journal-title":"Cancer Res"},{"issue":"5","key":"2021012107025211400_pkaa063-B34","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1753-4887.2010.00282.x","article-title":"Leucine metabolism in regulation of insulin secretion from pancreatic beta cells","volume":"68","author":"Yang","year":"2010","journal-title":"Nutr Rev"},{"issue":"9","key":"2021012107025211400_pkaa063-B35","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1056\/NEJM199508313330903","article-title":"Metabolic effects of metformin in non-insulin-dependent diabetes mellitus","volume":"333","author":"Stumvoll","year":"1995","journal-title":"N Engl J Med"},{"issue":"1","key":"2021012107025211400_pkaa063-B36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diacare.13.1.1","article-title":"Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients","volume":"13","author":"Wu","year":"1990","journal-title":"Diabetes Care"},{"issue":"4","key":"2021012107025211400_pkaa063-B37","doi-asserted-by":"crossref","first-page":"e61537","DOI":"10.1371\/journal.pone.0061537","article-title":"Metformin downregulates the insulin\/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners","volume":"8","author":"Sarfstein","year":"2013","journal-title":"PLoS One"},{"issue":"30","key":"2021012107025211400_pkaa063-B38","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1523\/JNEUROSCI.2904-18.2019","article-title":"Metformin promotes anxiolytic and antidepressant-like responses in insulin-resistant mice by decreasing circulating branched-chain amino acids","volume":"39","author":"Zemdegs","year":"2019","journal-title":"J Neurosci"}],"container-title":["JNCI Cancer Spectrum"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jncics\/advance-article-pdf\/doi\/10.1093\/jncics\/pkaa063\/33511615\/pkaa063.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jncics\/article-pdf\/4\/6\/pkaa063\/35929255\/pkaa063.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jncics\/article-pdf\/4\/6\/pkaa063\/35929255\/pkaa063.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T12:24:04Z","timestamp":1611231844000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jncics\/article\/doi\/10.1093\/jncics\/pkaa063\/5873525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,18]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11,15]]}},"URL":"https:\/\/doi.org\/10.1093\/jncics\/pkaa063","relation":{},"ISSN":["2515-5091"],"issn-type":[{"value":"2515-5091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12]]},"published":{"date-parts":[[2020,7,18]]},"article-number":"pkaa063"}}